Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1) | Patent Application Number 16648388

16648388
Not Appealed
Patent NumberUS 12134790 B2
Publication NumberUS 20200263153 A1
Filled DateSep 26, 2018
Priority DateSep 27, 2017
Inventor/ApplicantsAndre MAROZSAN
Andre Marozsan
Tayeba Khan
Kim Askew
Kim ASKEW
Tayeba KHAN
ExaminesCHOWDHURY, IQBAL HOSSAIN
Art Unit1656
Technology Center1600
Assignments
Inozyme Pharma Inc.
Current
Inozyme Pharma Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.